News, Insights & Stories
Stay up to date with the latest news and updates from Tanner. Here we highlight our work, partnerships, and ongoing efforts to improve access to critical medicines worldwide.
For media or press inquiries, please email us.
Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®
Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA.
Max Global Experience: Uganda
Tanner Pharma Group is proud to serve as the title sponsor for The Max Foundation’s "Max Global Experience: Uganda," an expedition to raise awareness and funds for increased cancer treatment access in Africa.
Tanner Pharma Group Formed from Merger of Tanner Pharmaceuticals & BurnsAdler Pharmaceuticals
Tanner Pharmaceuticals, Inc. and BurnsAdler Pharmaceuticals have merged to form Tanner Pharma Group.
Tanner Pharma Group Signs Exclusive Distribution Agreement with Merz North America for Named Patient Sales of Cuvposa® (glycopyrrolate) oral solution into Emerging Markets
The agreement names Tanner Pharma Group as Merz North America’s sole Named Patient distributor of Cuvposa ® (glycopyrrolate) oral solution in Latin America where Cuvposa ® (glycopyrrolate) oral solution is not yet registered.